-
Diagnostics World Contributed Commentary | Lateral flow immunoassays are simple yet powerful diagnostic tools, offering user-friendly, reliable, and low-cost testing. The goal now is to make the technology increase in signal intensity to produce less ambiguous results.
Dec 12, 2017
-
Diagnostics World Brief | Sarah Cannon announced that several of its affiliated programs will participate in a new study, called STRIVE, which focuses on developing a test for early breast cancer detection.
Dec 8, 2017
-
Healthegy |
The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this Medtech Talk Podcast, Michael Abramoff, MD, PhD, president, director and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.
Dec 7, 2017
-
Seeking Alpha |
Quanterix has proposed terms for its $50 million U.S. IPO. The company plans to sell 3.34 million shares of common stock at $15.00 per share.
Dec 6, 2017
-
Diagnostics World | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Teladoc, Celmatix, ANGLE, and more.
Dec 5, 2017
-
Diagnostics World Brief | Vanderbilt University Medical Center announced integration of FDNA’s Face2Gene suite of applications into the Vanderbilt Center for Undiagnosed Diseases workflow to evaluate difficult-to-diagnose patients in their role as part of the National Institutes of Health (NIH) Undiagnosed Disease Network (UDN).
Dec 4, 2017
-
OncLive | The FDA announced that it has approved the FoundationOne CDx assay. The Centers for Medicare & Medicaid Services issued a simultaneous announcement saying the next-generation sequencing-based in vitro diagnostic test will be covered by insurance.
Dec 1, 2017
-
Forbes | One of the most significant inefficiencies in our healthcare system is the inaccessibility to life-saving lab tests. EverlyWell is changing that narrative by making lab testing accessible and meaningful for consumers.
Nov 30, 2017
-
Diagnostics World | AliveCor today announced Food and Drug Administration clearance of KardiaBand in the U.S., a band for the Apple Watch with an embedded electrocardiogram device.
Nov 30, 2017
-
Xconomy | This year, money has been funneling into companies that apply artificial intelligence to healthcare, from diagnostics to speech recognition software. The latest recipient is New York-based Prognos, which says it just closed a $20.5 million Series C round from a group of prominent insurers, drug makers, and venture capital investors.
Nov 28, 2017
-
The DNA Exchange |
Ilana Löwy's new book, Imperfect Pregnancies: A History of Birth Defects & Prenatal Diagnosis (Johns Hopkins University Press, 2017) is more than just a recitation of discoveries and events. The author, an emerita research fellow at the French National Institute of Health and Medical Research, argues that prenatal testing can best be understood in the context of Michel Foucault's concept of a dispositif - loosely speaking, the institutions, social factors, laws, regulations, scientific and professional practices that create, maintain, and reinforce a body of knowledge and give it power.
Nov 28, 2017
-
Diagnostics World | Molecular Medicine Tri-Conference will celebrate its 25th anniversary next February in San Francisco. Here are a few of the talks we’ve marked so far.
Nov 27, 2017